First Page | Document Content | |
---|---|---|
Date: 2010-06-26 20:45:09Francis M. Mullen Diversion Investigator DEA United States federal executive departments Bureau of Narcotics and Dangerous Drugs Illegal drug trade Clandestine chemistry Law Thomas J. Harrigan FBI agents Drug Enforcement Administration United States Department of Justice | Add to Reading ListSource URL: www.deaeducationalfoundation.orgDownload Document from Source WebsiteFile Size: 1,27 MBShare Document on Facebook |
MISSOURI PHARMACY DIVERSION CONFERENCE 2016 WHEN:DocID: 1rcnw - View Document | |
Methamphetamine: The Resurgence of Manufacturing After Oklahoma House Bill 2176 Rashi K. Shukla E. Elaine Bartgis University of Central OklahomaDocID: 1qrcP - View Document | |
MISSOURI PHARMACY DIVERSION CONFERENCE 2016 WHEN:DocID: 1or7O - View Document | |
Steps to Take to Add Schedule II (Medications Containing Hydrocodone only) to Your Controlled Substance Prescriptive Authority Effective August 28, 2015, sectionRSMo grants permission for APRNs who have been dDocID: 1mdh4 - View Document | |
Microsoft Word - Memo for publishing on new BNDD rules[removed]docxDocID: RoEV - View Document |